Sign Up to like & get
recommendations!
1
Published in 2023 at "Experimental Physiology"
DOI: 10.1113/ep090849
Abstract: What is the central question of this study? Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce cardiovascular risk in patients with both diabetic and non‐diabetic kidney disease: can SGLT2 inhibition improve renal pressure natriuresis (PN), an important…
read more here.
Keywords:
inhibition improve;
glucose cotransporter;
pressure;
pressure natriuresis ... See more keywords